Line 18: | Line 18: | ||
Thanks to [[Team:Aix-Marseille/HP/Interviews|Jacques VAN HELDEN interview]] we put attention to the risk of recombination between M13KO7 and the phagemid. This question matter because we aim to create PLPs that aren't able to replicate and thus spread in the environment. Therefore, we test this possibility along our [[Team:Aix-Marseille/M13_test|wetlab tests]]. | Thanks to [[Team:Aix-Marseille/HP/Interviews|Jacques VAN HELDEN interview]] we put attention to the risk of recombination between M13KO7 and the phagemid. This question matter because we aim to create PLPs that aren't able to replicate and thus spread in the environment. Therefore, we test this possibility along our [[Team:Aix-Marseille/M13_test|wetlab tests]]. | ||
− | '''As p5 reconized M13ori, will the bacterium produces only PLPs or will it also produces replicative phages ?'''. | + | Here we wanted to answer a single question : '''As p5 reconized M13ori, will the bacterium produces only PLPs or will it also produces replicative phages ?'''. |
==First iteration of the model== | ==First iteration of the model== |
Revision as of 09:27, 24 October 2017
Engineered M13 modelling
Contents
Our project, KILL XYL will be a cure against the disease caused by the plant pathogen Xylella fastidiosa. One of the solution that we want to use is to engineered phage-like particles (PLPs), that will inject toxic genes into the bacterium. Phage systems, like M13, have been employed in biotechnological applications, most prominently in the identification and maturation of medically-relevant binding molecules through phage display [1].
However, production of phages as M13 have longterm consequences in E. coli metabolism[2]. M13 has a unique lifecycle among phages. One of the crucial event of his multiplication is the packaging of it's own DNA in the capsid. To do so, M13 uses it's protein 5 (p5) to target M13 origin of replication (M13ori). This step is crucial for the phage formation.
Moreover, we wanted that our phage became non-replicative to limit the spread of GMOs in the environment. That led to the creation of phage-like particles (PLPs). The design of these PLPs need the genome of M13 modified to stop the replication and the addition of a phagemid in the factory cell E.coli. Therefore, to create PLPs we use a modified M13 genome (M13KO7) that has several gene insert in it M13ori and we intgrate a phagemid with a M13ori.
Thanks to Jacques VAN HELDEN interview we put attention to the risk of recombination between M13KO7 and the phagemid. This question matter because we aim to create PLPs that aren't able to replicate and thus spread in the environment. Therefore, we test this possibility along our wetlab tests.
Here we wanted to answer a single question : As p5 reconized M13ori, will the bacterium produces only PLPs or will it also produces replicative phages ?.
First iteration of the model
We started with an excessively simple model to see wether our understanding of our system was profound enough to allow room for such simplifications. We made the following assumptions in this spirit:
Which led to the following model:
Assumption | Reasonning |
---|---|
Neglecting cooperative effects | |
Constant rate of p5 transcription/traduction | |
One M13KO7 per factory cell | |
Phage assembly isn't a limiting factor | |
Neglecting stochasticity |
insérer image que j'ai dans la présentation que j'ai faite, mais en mieux dessinée / plus travaillée / classe / raccord avec le reste du thème graphique + comment je mets les images sur le site pour qu'elle s'intègrent dans le wiki? Est-ce que je les met sur internet sinon?
Second iteration
This time, we decided to adapt the model of a "wild-type" M13's biology [2][3] to fit our own engineered version of M13 and better inform wetlab experiments, as well as explain some of their preliminary findings!
Model validation: compare particle profile to that obtained in wetlab
--> Insufficient p3 could cause the packing of several DNA molecules per phage.
What is the ideal number of plasmid copies if we produce p3 on a different plasmid?
Wet-lab and dry-lab back and forth
References
- ↑ Salmond, G. P. C. & Fineran, P. C. A century of the phage: past, present and future. Nat Rev Micro 13, 777–786 (2015).
- ↑ 2.0 2.1 Smeal et al, Simulation of the M13 life cycle I: Assembly of a genetically-structured deterministic chemical kinetic simulation, Virology, 500, January 2017
- ↑ Smeal et al, Simulation of the M13 life cycle II: Investigation of the control mechanisms of M13 infection and establishment of the carrier state, Virology, 500, January 2017